Implication of endogenous opioid system in the learned helplessness model of depression

This publication has 44 references indexed in Scilit:

• Association of beta-endorphin with specific clinical symptoms of depression
  American Journal of Psychiatry, 1992
• Antidepressant-type effects of endogenous enkephalins protected by systemic RB 101 are mediated by opioid δ and dopamine D1 receptor stimulation
  European Journal of Pharmacology, 1992
• Opioid δ agonists and endogenous enkephalins induce different emotional reactivity than μ agonists after injection in the rat ventral tegmental area
  Psychopharmacology, 1991
• Comparison of the behavioural effects induced by administration in rat nucleus accumbens or nucleus caudatus of selective ? and ? opioid peptides or kelatorphan an inhibitor of enkephalin-degrading-enzymes
  Psychopharmacology, 1988
• Involvement of endogenous enkephalins in the mouse ‘behavioral despair’ test
  European Journal of Pharmacology, 1984
• Interaction of tricyclic antidepressants with opiate receptors
  Biochemical Pharmacology, 1980
• Escape deficits induced by uncontrollable stress: Antagonism by dopamine and norepinephrine agonists
  Behavioral and Neural Biology, 1980
• The opiate antagonist naloxone modifies the effects of electroconvulsive shock (ECS) on respiration, blood pressure and heart rate
  Brain Research, 1979
• Enkephalin may mediate euphoria and drive-reduction reward
  Nature, 1977
• Effects of some narcotics and antagonists on synaptosomal 3H-norepinephrine uptake
  Life Sciences, 1972